Company profile

Takeda Pharmaceutical Co Ltd Insider Trading

TAK

Every SEC Form 4 insider trading filing for Takeda Pharmaceutical Co Ltd (TAK) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
NYSE
Sector
Pharmaceutical Preparations
CIK
0001395064
Filings
50
Insiders
25
Last filing
2026-08-19

Activity summary

Recent insider activity is bearish. Over the last 30 days, insiders net sold $9.9M across 17 transactions.

Quarterly balance

Buy and sell value by quarter, Q2 26 to Q3 26. Takeda Pharmaceutical Co Ltd insiders are net sellers across the period shown.

Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $135.6M.

90 day insight

Over the last 90 days, Takeda Pharmaceutical Co Ltd insiders bought $0 (25 transactions) and sold $135.2M (24 transactions).

  • Most active insider: Kim Julie So-Young with 6 transactions totaling $1.5M.
  • Largest single sale: $82.0M by Furuta Milano on Jul 10, 2026.
  • 4% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity is mixed — buys and sales are roughly balanced.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 19, 2026Plump Andrew StewartTAK
Sale10b5
19,651$18.49$363K
Aug 18, 2026Greenway Nicola Deidre PetalTAK
Sale
12,980$18.11$235K
Aug 11, 2026Shannon Elaine MaryTAK
Sale
20,363$17.55$357K
Aug 10, 2026Greenway Nicola Deidre PetalTAK
Sale
6,774$17.10$116K
Aug 10, 2026Kim Julie So-YoungTAK
Sale
89,090$17.10$1.52M

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=TAK" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Furuta MilanoChief Financial Officer1 filing$82.0M
Iijima MasamiDirector1 filing$10.6M
Tsusaka MikiDirector1 filing$10.6M
Gillis StevenDirector1 filing$5.7M
Maraganore JohnDirector1 filing$5.7M

Institutional Ownership

Top 13F-HR holders of Takeda Pharmaceutical Co Ltd as of 2026-06-30

↓ decreasing
Total reported AUM
$234.9M
QoQ change
-86.8%
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$57.6M
3.6M shares
#2
Managed Asset Portfolios, LLC
CIK 0001600999
$29.2M
1.8M shares
#3
Envestnet Asset Management Inc
CIK 0001407543
$25.6M
1.6M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →